Gastrointestinal Stromal Tumor Clinical Trials in Guangzhou
4 recruitingGuangzhou, China
Showing 1–4 of 4 trials
Recruiting
Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled30 locationsNCT05489237
Recruiting
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
Unresectable Solid TumorGastrointestinal Stromal TumorsRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD74 enrolled1 locationNCT05461664
Recruiting
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs
Gastrointestinal Stromal Tumors
First Affiliated Hospital, Sun Yat-Sen University60 enrolled1 locationNCT06431451
Recruiting
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Unresectable Solid TumorGastrointestinal Stromal TumorsRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD74 enrolled1 locationNCT05464875